This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • NSCLC Burden of Illness Study (LuCaBIS)
Clinical trial

NSCLC Burden of Illness Study (LuCaBIS)

Read time: 1 mins
Last updated:17th Jan 2013
The aim of this observational study is to identify and quantify the humanistic and economic burden of illness of patients with complete resection (no residual disease) of stage IB-IIIA NSCLC in three European countries (France, Germany, and the United Kingdom [UK]). Data collection will be conducted through patient medical record abstraction and patient survey.
Category Value
Study start date 2013-01-17

View full details